Category Archives: Business and Investments

Latest From Business and Investments

Small Company with Big Dreams – #BIF16 Fireside Chat with Rachel Haurwitz


Rachel Haurwitz is young. So is her company. Caribou was founded in 2011 and Haurwitz became the CEO in 2012 when she finished her PhD. In 2014 Haurwitz landed on  FORBES 30 Under 30 list for Science & Healthcare. And then in 2016 she was selected for Fortune magazine’s 2016 “40 Under 40” list, the publication’s annual ranking of the most influential young people in business. During a Fireside Chat today at the BIO Investor Forum, Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Does Big Company M&A Impact Small Company M&A?


Over the last few years, we have seen significant consolidation among the large drug manufacturers, with both franchise swapping and mergers of equals – but what is the impact on small biotechs? At the BIO Investor Forum, (held at the Westin St. Francis in San Francisco today), a panel session moderated by Matthew Hudes, Chief Executive Officer of bdlBiologx, set out to answer that very question. The panelists, all seasoned industry veterans, came from a Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Investor Forum is Next Week: Oct. 18-19


Now in its 15th year, the BIO Investor Forum is set for Oct. 18 – Oct. 19 at the Westin St. Francis in San Francisco.  The event will feature 10 educational panel sessions, three ”fireside chat” interviews with senior executives, more than 170 company presentations, and hundreds of One-on-One Partnering™ meetings. BIO is pleased to announce that four of the 2016 Fiercest Women in Biopharma will be speaking this year: Charlotte Hubbert, PhD, Partner, Gates Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Closing the Gender Gap in Biotech through SBIR/STTR Funding


Although progress has been made, there is no denying the biotech industry continues to have a large gender gap. Women hold only 16 percent of the senior management posts at the top pharma companies, and of senior executive positions at emerging companies — the 10 companies that raised most in venture capital A rounds in 2014 — only 12 (17 percent) were filled by women.* The National Center for Advancing Translational Sciences (NCATS), part of Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BUZZ of BIO Winners Announced for the 2016 BIO Investor Forum


BIO is pleased to announce the winners of the 2016 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Ten pioneering biotech companies were nominated in each of two categories—Early Stage Entrepreneurs and Late Stage Leaders; voting closed August 23. Sequella, a private, clinical-stage pharmaceutical company, won in the Early Stage Entrepreneurs category. The company is focused on antibiotic-resistant bacterial diseases and improved treatments for serious infectious diseases. Sequella’s stated business Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,